Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
ClinicalTrials.gov study NCT04221152. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
ClinicalTrials.gov study NCT04869800. IPD Sharing: NO. Countries: 1. Publications: 0.
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
ClinicalTrials.gov study NCT07331389. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT06952231. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Cohort Study of Children With GSD1b Receiving Empagliflozin
ClinicalTrials.gov study NCT04986735. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
ClinicalTrials.gov study NCT06145360. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
ClinicalTrials.gov study NCT06926660. IPD Sharing: YES. Countries: 24. Publications: 0.
Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin
ClinicalTrials.gov study NCT03510000. IPD Sharing: NO. Countries: 1. Publications: 0.
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT07003191. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
ClinicalTrials.gov study NCT06507657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
ClinicalTrials.gov study NCT06531824. IPD Sharing: YES. Countries: 18. Publications: 0.
Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF
ClinicalTrials.gov study NCT07169981. IPD Sharing: NO. Countries: 1. Publications: 0.
Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mel
ClinicalTrials.gov study NCT05232071. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
ClinicalTrials.gov study NCT06762314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
ClinicalTrials.gov study NCT07322237. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients
ClinicalTrials.gov study NCT05147090. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in Patients With Glomerulonephritis
ClinicalTrials.gov study NCT05283057. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin
ClinicalTrials.gov study NCT05036421. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial
ClinicalTrials.gov study NCT07141355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
ClinicalTrials.gov study NCT06424288. IPD Sharing: YES. Countries: 30. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.